Showing results (31-40 of 291) with videos related to
Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cellsD Rosa, S Campagnoli, C Moretto, et al.Molecular Medicine (Cambridge, Mass.)|July 28, 2001
Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected personsC Agrati, G D'Offizi, P Narciso, et al.Journal of Viral Hepatitis|April 23, 2014
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trialP Colombatto, M R Brunetto, A M Maina, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytesP Botarelli, B A Houlden, N L Haigwood, et al.Infection and Immunity|May 1, 1994
Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processingA di Tommaso, M T de Magistris, M Bugnoli, et al.The EMBO Journal|February 28, 2001
CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifsK Kitadokoro, D Bordo, G Galli, et al.Cellular Immunology|December 1, 1984
Complement activation by cell-associated immune complexes in contact sensitivityA Salerno, M Brai, F Dieli, et al.Seminars in Immunology|November 5, 2013
The CD4-centered universe of human T cell subsetsJ Geginat, M Paroni, F Facciotti, et al.Immunological Reviews|May 12, 2000
Life, activation and death of intrahepatic lymphocytes in chronic hepatitis CN M Valiante, A D'Andrea, S Crotta, et al.Pageof 30